key: cord-1053583-h9ubsv5o
authors: Benoit, Patrick; Point, Floriane; Gagnon, Simon; Kaufmann, Daniel E.; Tremblay, Cécile; Harrigan, Richard Paul; Hardy, Isabelle; Coutlée, François; Lapierre, Simon Grandjean
title: Impact of cobas PCR Media Freezing on SARS-CoV-2 Viral RNA Integrity and Whole Genome Sequencing Analyses
date: 2021-08-21
journal: Diagn Microbiol Infect Dis
DOI: 10.1016/j.diagmicrobio.2021.115521
sha: dec90af688fa0cc9b32777103aa8e729bee9fd5f
doc_id: 1053583
cord_uid: h9ubsv5o

SARS-CoV-2 whole genome sequencing is a molecular biology tool performed to support many aspects of the response to the pandemic. Freezing of primary clinical nasopharyngeal swabs and shipment to reference laboratories is usually required for sequencing. Cobas PCR Media transport medium facilitates high throughput SARS-CoV-2 RT-PCR analyses on cobas platforms. The manufacturer doesn't recommend freezing this transport medium because of risks of degrading molecular templates and impairing test results. Our objective was to compare the quality and results of SARS-CoV-2 genomic sequencing when performed on fresh or frozen samples in cobas PCR Media. Viral genome sequencing was performed using Oxford Nanopore Technologies MinION platform. Sequencing performance, quality and results did not significantly differ between fresh and frozen samples (n=10). Freezing of cobas PCR Media does not negatively affect SARS-CoV-2 RNA sequencing results and it is therefore a suitable transport medium for outsourcing sequencing analyses to reference laboratories.

SARS-CoV-2 viral genomic sequencing plays an important role in the short and long-term responses to the COVID-19 pandemic including global and national surveillance of the virus evolution, understanding of SARS-CoV-2 natural history of disease and outbreak investigations [1] [2] [3] [4] . Viral whole genome sequencing primarily occurs in reference laboratories and is rarely performed where clinical diagnosis or outbreak investigations happen. Moreover, the capacity for sequencing remains limited compared to the number of submitted samples, which lead to delays and a backlog for sequencing analyses. Therefore, freezing of primary samples is often required prior to viral genomic amplification and sequencing.

Cobas PCR Media is a transport medium developed by Roche that simplifies linkage between pre-analytical sampling and analytical testing and is adapted for high throughput analyses on cobas multianalyzer PCR platforms. It contains guanidine hydrochloride which is a denaturing agent used to dissociate nucleoproteins and inactivate RNases. The manufacturer does not recommend freezing the cobas PCR Media in its package insert because of risks of molecular template denaturation as opposed to other transport media [5] . Freezing of other transport media was previously shown not to negatively impact the detection of SARS-CoV-2 by RT-PCR [6] .

However, it is unknown whether, and how, freezing of cobas PCR Media indeed denatures SARS-CoV-2 RNA and if it negatively affects viral genomic sequencing.

In this study, we compared the quality and results of SARS-CoV-2 whole genome sequencing between fresh and frozen samples obtained from combined oral and nasopharyngeal swabs (ONPS). We used matched split samples collected in cobas PCR Media and either processed following collection and storage at 4C or frozen for one week at -80C and thawed prior to sequencing. Our protocol and analysis address the necessity for most clinical microbiology laboratories to refer frozen primary clinical samples that were used for diagnostic purposes to reference laboratories in order to access viral genomic information.

Ten clinical samples were included in this study. All samples were a combined ONPS placed in cobas PCR Media transport medium submitted to our laboratory and initially found to be positive for SARS-CoV-2 using the FDA emergency use authorization (EUA) approved and validated cobas 8800 automated RT-PCR system which simultaneously tests both the ORF1 a/b and Egene viral molecular targets [7] . To assess the impact of viral load or initial amount of RNA template on sequencing, we purposively included samples testing positive at a broad range of cycle threshold (Ct) from 14.4 to 34.7 for the ORF1 a/b target. This strategy ensured inclusion of samples with high and low Ct to verify if the effect of freezing is only significant with lower or higher viral load samples.

Following initial positive RT-PCR testing, samples were split in equal volumes. The first half of each samples was maintained at 4C, according to manufacturer's recommendation, and then processed for whole genome sequencing as described below. The second half of each sample was frozen at -80C for 7 days and thawed. RT-PCR was then repeated using the same cobas 8800 system and viral genomic sequencing was performed using identical methods.

Viral RNA was extracted from 0.2 mL of cobas PCR Media using Maxwell® 16 instrument (Promega, Madison, WI, USA) for final elution in 30L. Viral whole genome sequencing was performed using the ARTIC Network V3 protocol on Oxford Nanopore Technologies (ONT) (Oxford, United Kingdom) MinION® long read sequencing platform. Since its initial publication online in January 2020, the ARTIC protocol has become one of the most widely used approach to SARS-CoV-2 genomic sequencing. This protocol has yielded a significant sequence contribution to the GISAID global database and is currently used for surveillance by many public health agencies [8, 9] . Briefly, genome amplification was performed by reverse transcriptase multiplex PCR using nCoV-2019 V3 primer combinations (Integrated DNA Technologies). This set of primers was previously shown to produce high genomic coverage with low variance on the whole viral genome [8] . RT-PCR amplicons were assessed by Qubit® fluorometric DNA Quantification (Thermo Fisher Scientific, Waltham, MA, USA). For samples with post RT-PCR DNA quantity below 250 ng, we omitted the dilution step of the sample in 45 L of molecular grade water before library preparation as recommended in the ARTIC protocol. Such low inoculums were observed in three samples with both ORF1 a/b and E-gene targets Cts over 30 (samples 1, 2, 3). Sequencing libraries were prepared following ONT protocol for genomic DNA with native barcoding and using 9.4.1 flow cells on the MinION® platform. Raw sequencing reads fast5 files were base called with high accuracy using ONT proprietary software Guppy (v3.4.5). Reads were demultiplexed and filtered using the online available ARTIC network bioinformatic pipeline solution [10]. This filtering process includes exclusion of sequencing reads respectively below 400 and above 700 base pairs which do not correspond to expected 7 amplicons length resulting from the RT-PCR primer set. Reads were mapped to the Wuhan-Hu-1 SARS-CoV-2 reference genome (GeneBank accession number MN908947.3) using minimap2 (v2.17). Predominantly sequenced nucleotides at positions for which a minimal depth of 20 reads had been achieved were used to generate consensus viral genomic sequences. Potential subpopulations or mixed infections were not considered, and hence a unique consensus sequence was generated for each isolate.

We compared mean sequencing Q-scores with corresponding error rates and accuracy, single nucleotide polymorphisms (SNPs) identification and diversity of sequenced alleles on identified SNP genomic positions. We used those later metrics as surrogate markers of post-freezing viral RNA integrity. Q-scores represent ONT's sequencing platform and base calling software internal assessment of sequencing read quality. The Q-score of a given base is defined as Q = 10log 10 (e)

where (e) is the estimated probability of the base call being wrong. We used a two-tailed paired samples t-test with an alpha value of 0.05 to compare pre-and post-freezing variables. All statistical analyses were performed using GraphPad Prism (San Diego, CA USA).

To simulate prospective outbreak investigation, we supplemented the pre-and post-freezing sequence datasets with a back catalog of 50 SARS-CoV-2 genomic sequences from our institution (unpublished data) hence generating two mocked nosocomial viral pangenomes. We independently analyzed both augmented data sets as if searching for potential transmission clusters. Consensus sequences were compared, and phylogenetic trees were built using UGENE (v37) with the PHYLIP Neighbor Joining method without bootstrapping. To simulate national 8 surveillance and assessment of circulating viral clades, we independently compared the pre-and post-freezing sequence datasets with published and well described SARS-CoV-2 reference genomes submitted to Nextstrain (https://nextstrain.org/sars-cov-2/) [11] .

All laboratory testing including sequencing and data analyses were performed in Centre Hospitalier de l'Université de Montréal. Patients' symptoms nature and relative temporality with clinical sampling, or potential person to person transmission events were not taken into consideration.

SARS-CoV-2 sequences from this study are available at GenBank under continuous accession numbers MW309425 to MW309442.

Upon initial testing after maintenance of clinical samples at 4C in cobas PCR Media, RT-PCR Cts ranged from 14.4 to 34.7 and 14.9 to 34.9 respectively for the ORF1 a/b and E-gene targets.

After freezing for 7 days at -80C, RT-PCR Cts ranged between 17.8 to 31.8 and 17.9 to 33.8 for the same targets. No statistically significant difference was observed between pre-and postfreezing Cts for the ORF1 a/b target (p-value 0.64). One sample only became positive on the Egene target after freezing. Excluding this sample from the analysis, post-freezing Cts for the Egene target were 1.1 Ct higher after freezing (p-value 0.01) ( Table 1) .

No statistically significant difference was observed between the sequencing yields before or after freezing. Indeed, freezing did not negatively impact the total number of sequenced bases and mapped reads with pre-/ post-freezing mean deltas of 11 Mb (p-value 0.57) and 938 reads (pvalue 0.31) for those key metrics. Also importantly, 20X sequencing depth, allowing for wild type or variant allelic identification within our protocol, was achieved for an average of 83.9% and 83.7% of the viral genome respectively before and after freezing (p-value 0.90) ( Table 2) .

Such similarity was also observed for all other evaluated depth thresholds (1X, 5X, 10X, 50X).

As expected, sequencing data yield, depth and coverage were inversely correlated to the Ct value both in pre-(p-value 0.0007) and post-freezing (p-value 0.0003) samples. Less sequencing data was hence generated in the sub-group of low viral inoculum and high Ct samples 1, 2 and 3 but freezing did not negatively impact sequencing yields in this subgroup either (Fig. 1) .

No statistically significant decrease was observed in Q-scores (p-value 0.07) and base call accuracy (p-value 0.10) after freezing (Table 3) . Except for samples 1 (ORF1 a/b Ct 34.74) and 2 (ORF1 a/b Ct 32.16), freezing did not impact SNP detection and identified mutations were identical in both sequencing analyses. Looking in more depth at each single read for those specific mutation sites, the percentage of alternate bases leading to SNP calling did not significantly change after freezing (p-value 0.31). This ratio of variant versus wild type alleles at each mutation site was the same before and after freezing and suggests that the viral molecular template was not significantly degraded by the freezing process in cobas PCR Media.

In the mocked outbreak investigation, samples with higher genomic similarity were identified.

Although our study was not a molecular epidemiology study and did not include clinical correlation with putative transmission events, those molecular clusters were identical in both preand post-freezing analyses (Fig. 2) . For the surveillance clade typing simulated application, phylogenetic placement was also identical in the pre-and post-freezing mocked data sets (Fig.   3) . For viral clade typing and comparison to reference genomes, samples 1 and 2 could not be included in the analysis because of too small genomic coverage. All phylogenetic placement results were expected and in agreement with previously described findings on identical SNP typing.

In our study, a single freeze -thaw cycle of ONPS clinical samples in cobas PCR Media did not significantly impact analytical sensitivity of SARS-CoV-2 RT-PCR on cobas 8800® automated system on this limited set of samples. Although we observed a Ct increase of 1.1 (p-value 0.01) after freezing for the E-gene target, one of our samples was also found to be positive for this target only after freezing. Freezing the sample in cobas PCR Media did not degrade viral molecular templates and did not negatively affect viral genomic sequencing analyses. Khiri et al had previously shown that freezing of cervical samples in cobas PCR Media did not negatively impact the sensitivity of PCR for human papillomavirus detection [12] . Our study confirms this holds true for SARS-CoV-2. To our knowledge, this is the first study to formally evaluate the impact of freezing clinical samples in cobas PCR Media for downstream sequencing analyses either for SARS-CoV-2 or for any other target pathogen or molecular template. Our study confirms the ability of cobas PCR Media to maintain SARS-CoV-2 genomic RNA at -80C for 11 subsequent sequencing analyses. Note that the PCR amplicons generated in this study are relatively small (~400 bp), so this protocol may be more robust to RNA damage than methods which require long, intact starting molecules. Our results suggest that other transport media that contain guanidine hydrochloride such as PrimeStore molecular transport media (MTM), Zymo DNA/RNA Shield and Spectrum Solutions Saliva Collection Device could also be suitable for sequencing after freezing, subject to independent confirmation.

Our study included three samples with RT-PCR Cts above 30.0 which are considered to have a lower viral load. For those samples, SNP calling showed variability and genomic coverage was insufficient to allow detailed phylogenetic analyses. This phenomenon was observed both before and after freezing and is hence believed to be due to low viral inoculum rather than transport medium related viral RNA denaturation. Our study included only 10 samples. Although the limited number of samples represents the main weakness of our research, the extensive comparability between pre-and post-freezing sequencing results suggests that a higher denominator would not have led to different conclusions. Since the sequencing measures of quality did not decrease after freezing for this specific transport medium, we believe that similar results would be found for other sequencing methods, but this was not verified by our study. It is possible that a freezing period longer than 7 days would have led to worse sequencing results after thawing but our protocol did not assess such longer-term effect. Seven days represents a sufficient delay for transportation to reference laboratories performing viral sequencing and our study hence provides meaningful information to clinical laboratories involved in routine diagnostic testing. The impact of additional cycles of freezing and thawing is likely more significant than the duration of the freezing period, but this was not assessed here.

Our study demonstrates that the freezing of cobas PCR Media at -80C does not affect viral genomic sequencing quality and results for SARS-CoV-2. The consistent results between preand post-freezing support potential secondary use of diagnostic oral and nasopharyngeal swab material for viral sequencing without requirement for additional clinical sampling. Our findings will simplify the collection and storage of samples in laboratories where this transport medium is utilized.

Santé Québec, Roche Diagnostics (Laval, Canada) and CIHR/CITF grant VR2-173203. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. Table 2 -Difference in SARS-CoV-2 sequencing generated bases, reads and corresponding genomic coverage at various depth thresholds after 7-day freezing in cobas PCR Media. Samples are presented in decreasing order of Ct value on pre-freezing ORF1 a/b RT-PCR. 

Genomics and epidemiological surveillance

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

Rapid implementation of SARS-CoV-2 sequencing to investigate cases of healthcare associated COVID-19: a prospective genomic surveillance study

Covid-19: New coronavirus variant is identified in UK

Conditions for the Detection of SARS-CoV-2 by Use of Real-Time Reverse Transcription-PCR

Comparison of SARS-CoV-2 detection from combined nasopharyngeal/oropharyngeal swab samples by a laboratory-developed real-time RT-PCR test and the Roche SARS-CoV-2 assay on a cobas 8800 instrument

Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore

Genomic epidemiology of hCoV-19

10. Nick Loman WR, Andrew Rambaut. 2020. ARTIC-nCoV-bioinformaticsSOP

Nextstrain: real-time tracking of pathogen evolution

Cytological and virological medium performance and stability assessment using the 16

Cobas 4800 HPV test (Roche Diagnostics) used in France